This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

1Life Healthcare Yönetim

Yönetim kriter kontrolleri 4/4

Anahtar bilgiler

Amir Rubin

İcra Kurulu Başkanı

US$1.8m

Toplam tazminat

CEO maaş yüzdesi	39.0%
CEO görev süresi	5.5yrs
CEO sahipliği	0.05%
Yönetim ortalama görev süresi	2.5yrs
Yönetim Kurulu ortalama görev süresi	4yrs

Son yönetim güncellemeleri

Recent updates

1Life Healthcare, Inc. (NASDAQ:ONEM) Released Earnings Last Week And Analysts Lifted Their Price Target To US$54.00

Feb 28

Can You Imagine How Jubilant 1Life Healthcare's (NASDAQ:ONEM) Shareholders Feel About Its 129% Share Price Gain?

Feb 01

1Life Healthcare Sets Foundation For Future Growth

Dec 31

Are Insiders Selling 1Life Healthcare, Inc. (NASDAQ:ONEM) Stock?

Dec 18

1Life Healthcare Q3 2020 Earnings Preview

Nov 09

CEO Tazminat Analizi

Amir Rubin'un ücretlendirmesi 1Life Healthcare'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Dec 31 2022	n/a	n/a	-US$398m
Sep 30 2022	n/a	n/a	-US$392m
Jun 30 2022	n/a	n/a	-US$359m
Mar 31 2022	n/a	n/a	-US$306m
Dec 31 2021	US$2m	US$697k	-US$255m
Sep 30 2021	n/a	n/a	-US$167m
Jun 30 2021	n/a	n/a	-US$105m
Mar 31 2021	n/a	n/a	-US$94m
Dec 31 2020	US$199m	US$623k	-US$89m
Sep 30 2020	n/a	n/a	-US$100m
Jun 30 2020	n/a	n/a	-US$99m
Mar 31 2020	n/a	n/a	-US$80m
Dec 31 2019	US$14m	US$600k	-US$53m

Tazminat ve Piyasa: Amir 'nin toplam tazminatı ($USD 1.79M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 6.66M ).

Tazminat ve Kazançlar: Amir 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Amir Rubin (52 yo)

5.5yrs

Görev süresi

US$1,788,721

Tazminat

Mr. Amir Dan Rubin, MBA, has been the Chief Executive Officer and President at 1Life Healthcare, Inc. since August 2017 and has been its Chair, since September 2017. From January 2016 to August 2017, he se...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Amir Rubin	Chairman	5.5yrs	US$1.79m	0.049% $ 1.7m
Bjorn Thaler	CFO & Principal Financial Officer	3.8yrs	US$10.60m	0.011% $ 357.7k
Lisa Mango	General Counsel & Corporate Secretary	4.7yrs	US$5.02m	0.043% $ 1.5m
Andrew Diamond	Chief Medical Officer	3.4yrs	US$4.66m	0.012% $ 392.3k
Trent Green	Chief Operations Officer	1.1yrs	Veri yok	Veri yok
Vikas Agarwal	Chief Accounting Officer & Principal Accounting Officer	less than a year	Veri yok	0.0043% $ 147.3k
Stuart Parmenter	Chief Technology Officer	1.6yrs	Veri yok	Veri yok
Ken Goff	Vice President of Investor Relations	no data	Veri yok	Veri yok
Christopher Hollander	Chief Marketing Officer	less than a year	Veri yok	Veri yok
Christine Morehead	Chief People Officer	no data	Veri yok	Veri yok
Rajneesh Behal	Chief Quality Officer	no data	Veri yok	Veri yok
Jenni Vargas	Chief Strategy Officer	no data	Veri yok	Veri yok

2.5yrs

Ortalama Görev Süresi

51yo

Ortalama Yaş

Deneyimli Yönetim: ONEM 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.5 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Amir Rubin	Chairman	5.4yrs	US$1.79m	0.049% $ 1.7m
Bruce Dunlevie	Lead Independent Director	15.7yrs	US$239.92k	0.33% $ 11.3m
Mary Tocio	Independent Director	1.4yrs	US$255.59k	0.023% $ 785.6k
Paul Auvil	Independent Director	3.4yrs	US$239.92k	0.0062% $ 209.0k
Mark Blumenkranz	Independent Director	3.3yrs	US$212.13k	0.0022% $ 75.3k
Scott Taylor	Independent Director	1.7yrs	US$271.78k	0.0038% $ 128.6k
David Kennedy	Independent Director	15.7yrs	US$216.96k	0.0050% $ 170.7k
Freda Lewis-Hall	Independent Director	3.3yrs	US$212.13k	0.0022% $ 75.3k
Kalen Holmes	Independent Director	6.1yrs	US$232.13k	0.0022% $ 75.3k
Robert Schmidt	Independent Director	4.5yrs	US$47.50k	Veri yok

4.0yrs

Ortalama Görev Süresi

58yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: ONEM 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4 yıldır).

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2023/02/23 00:56
Gün Sonu Hisse Fiyatı	2023/02/21 00:00
Kazançlar	2022/12/31
Yıllık Kazançlar	2022/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Buradan daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları 'da mevcuttur.

Analist Kaynakları

1Life Healthcare, Inc. 23 Bu analistlerden 7, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum
Vikram Kesavabhotla	Baird
Sarah James	Barclays
David Larsen	BTIG

This company has been acquired

1Life Healthcare Yönetim

Yönetim kriter kontrolleri 4/4

Anahtar bilgiler

Son yönetim güncellemeleri

General Counsel & Corporate Secretary exercised options and sold US$211k worth of stock

General Counsel & Corporate Secretary exercised options and sold US$155k worth of stock

CFO & Principal Financial Officer exercised options and sold US$96k worth of stock

1Life Healthcare, Inc. Appoints Vikas Agarwal as Chief Accounting Officer and Principal Accounting Officer

High number of new directors

1Life Healthcare, Inc., Annual General Meeting, Jun 02, 2022

Recent updates

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

General Counsel & Corporate Secretary exercised options and sold US$211k worth of stock

Forecast to breakeven in 2025

General Counsel & Corporate Secretary exercised options and sold US$155k worth of stock

CFO & Principal Financial Officer exercised options and sold US$96k worth of stock

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Amazon receives FTC request for more information about One Medical deal

1Life Healthcare: Amazon Merger Unlikely To Face Regulatory Pushback

Second quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Amazon.com, Inc. (NasdaqGS:AMZN) entered into a definitive merger agreement to acquire 1Life Healthcare, Inc. (NasdaqGS:ONEM) for approximately $3.7 billion.

Amazon.com, Inc. (NasdaqGS:AMZN) entered into a definitive merger agreement to acquire 1Life Healthcare, Inc. (NasdaqGS:ONEM) for approximately $3.6 billion.

Price target increased to US$15.43

1Life Healthcare, Inc. Appoints Vikas Agarwal as Chief Accounting Officer and Principal Accounting Officer

1Life Healthcare jumps after report of takeover interest

1Life Healthcare, Inc.(NasdaqGS:ONEM) dropped from Russell 2000 Growth Index

Is 1Life Healthcare (NASDAQ:ONEM) A Risky Investment?

Price target decreased to US$13.85

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

1Life Healthcare, Inc. Provides Earnings Guidance for the Second Quarter Ending June 30, 2022 and for the Year Ending December 31, 2022

High number of new directors

1Life Healthcare, Inc., Annual General Meeting, Jun 02, 2022

Price target decreased to US$15.31

Is 1Life Healthcare (NASDAQ:ONEM) Weighed On By Its Debt Load?

Full year 2021 earnings: EPS and revenues exceed analyst expectations

1Life Healthcare, Inc. Provides Revenue Guidance for the Three and Twelve Months Ending December 31, 2022

1Life Healthcare, Inc. to Report Q4, 2021 Results on Feb 23, 2022

1Life Healthcare: Not So Healthy Heading Into 2022

Price target decreased to US$30.57

Chair, CEO & President exercised options to buy US$1.5m worth of stock.

Does 1Life Healthcare (NASDAQ:ONEM) Have A Healthy Balance Sheet?

Price target decreased to US$33.15

Third quarter 2021 earnings released: US$0.51 loss per share (vs US$0.13 loss in 3Q 2020)

High number of new directors

Price target decreased to US$35.69

High number of new directors

1Life Healthcare: Post-Merger Earnings Preview

Price target decreased to US$38.62

1Life Healthcare, Inc. (NasdaqGS:ONEM) completed the acquisition of Iora Health, Inc. from Temasek Holdings (Private) Limited and others.

1Life Healthcare: Why We Are Against The Merger

Consensus forecasts updated

Price target decreased to US$43.45

1Life Healthcare, Inc. Provides Earnings and Operating Guidance for the Third Quarter and Year 2021

Second quarter 2021 earnings released: US$0.30 loss per share (vs US$0.24 loss in 2Q 2020)

High number of new directors

Independent Director notifies of intention to sell stock

1Life Healthcare: Some Questions After Recent Events

Independent Director David Singer has left the company

Consensus forecasts updated

Price target decreased to US$51.50

Consensus forecasts updated

Forecast to breakeven in 2023

First quarter 2021 earnings released: US$0.29 loss per share (vs US$0.40 loss in 1Q 2020)

1Life Healthcare, Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2021

Health Check: How Prudently Does 1Life Healthcare (NASDAQ:ONEM) Use Debt?

Independent Director notifies of intention to sell stock

General Counsel & Corporate Secretary exercised options and sold US$365k worth of stock

Full year 2020 earnings released: US$0.75 loss per share (vs US$2.84 loss in FY 2019)

Price target raised to US$54.00

1Life Healthcare, Inc. (NASDAQ:ONEM) Released Earnings Last Week And Analysts Lifted Their Price Target To US$54.00

Price target raised to US$51.89

Full year 2020 earnings released: US$0.75 loss per share (vs US$2.84 loss in FY 2019)

Revenue beats expectations, earnings disappoint

1Life Healthcare, Inc. to Report Q4, 2020 Results on Feb 25, 2021

New 90-day high: US$55.03

Can You Imagine How Jubilant 1Life Healthcare's (NASDAQ:ONEM) Shareholders Feel About Its 129% Share Price Gain?

New 90-day high: US$47.71

Chair, CEO & President notifies of intention to sell stock

One Medical Begins Administering Vaccinations for Phase 1A Populations Who Work or Live in San Francisco